---

---

tags : Update    entities : Eli lilly and company   

save search

---

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.88 -0.77% 650K |

Health Technology

| -20.75% | O: 1.58% H: 0.58% C: -0.39%
NVS | $93.815 1.35% 410K |

Health Technology

| -2.3% | O: 0.24% H: 0.42% C: 0.4%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| -3.11% | O: 0.49% H: 0.84% C: -0.07%
TGTX | News | $13.735 -1.82% 1.2M |

Health Technology

| -9.39% | O: 0.71% H: 0.39% C: 0.13%
DTIL | $9.985 -6.86% 93K |

Health Technology

| -15.92% | O: 0.39% H: 4.22% C: 1.41%
precision business year update financial results

---

Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| -0.91% | O: -0.6% H: 0.45% C: 0.08%
MRUS | $40.04 -1.06% 230K |

Health Technology

| -15.71% | O: 2.3% H: 0.58% C: -2.69%
INCY | $52.45 -0.7% 530K |

Health Technology

| -11.94% | O: 0.38% H: 0.0% C: -3.07%
business year update financial results

---

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| -2.74% | O: -2.2% H: 2.39% C: 1.34%
ACRS | $1.235 0.41% 150K |

Health Technology

| 1.65% | O: 2.48% H: 10.48% C: -3.23%
year update therapeutics financial results

---

Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 28.87% | O: -1.66% H: 0.0% C: 0.0%
ACRS | $1.235 0.41% 150K |

Health Technology

| -77.09% | O: 1.12% H: 5.06% C: 0.92%
update therapeutics financial results

---

AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-11-03 (Crawled : 11:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 30.12% | O: 0.97% H: 0.0% C: 0.0%
ACIU | $2.38 8.8K |

Health Technology

| -16.49% | O: -4.91% H: 0.0% C: 0.0%
update financial results

---

Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 30.12% | O: 0.97% H: 0.0% C: 0.0%
MRUS | $40.04 -1.06% 230K |

Health Technology

| 87.1% | O: 3.51% H: 9.56% C: 9.56%
INCY | $52.45 -0.7% 530K |

Health Technology

| -2.13% | O: 0.52% H: 1.38% C: 1.11%
business update financial results

---

ProQR Therapeutics Provides Update on Ophthalmic Assets
Published: 2023-09-27 (Crawled : 11:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 36.17% | O: -0.26% H: 0.33% C: -0.02%
PRQR | $1.98 6.45% 62K |

Health Technology

| 31.03% | O: 0.0% H: 1.38% C: -4.83%
update therapeutics

---

Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer
Published: 2023-09-22 (Crawled : 12:00) - biospace.com/
MRK | $125.31 0.06% 2.3M |

Health Technology

| 17.46% | O: 0.46% H: 0.0% C: -0.82%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 32.8% | O: -2.93% H: 1.22% C: 0.32%
keytruda lung merck update cancer cell trials plus

---

Jazz Pharmaceuticals Announces Key Update to Leadership Team
Published: 2023-09-12 (Crawled : 12:30) - biospace.com/
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 28.0% | O: 0.75% H: 1.72% C: 1.41%
JAZZ | $109.03 -0.22% 66K |

Health Technology

| -21.52% | O: -0.1% H: 0.39% C: -0.45%
update pharmaceuticals

---

Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update
Published: 2023-08-07 (Crawled : 21:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 65.34% | O: 11.43% H: 6.32% C: 3.08%
MRUS | $40.04 -1.06% 230K |

Health Technology

| 63.87% | O: 3.79% H: 1.72% C: -11.69%
INCY | $52.45 -0.7% 530K |

Health Technology

| -16.99% | O: 2.58% H: 0.41% C: -1.13%
business update financial results

---

Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-04 (Crawled : 12:20) - precisionbiosciences.com
NVS | $93.815 1.35% 410K |

Health Technology

| -8.78% | O: -0.38% H: 0.73% C: 0.15%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 66.3% | O: -0.53% H: 0.0% C: 0.0%
DTIL | $9.985 -6.86% 93K |

Health Technology

| 1814.63% | O: -0.95% H: 0.0% C: 0.0%
business update financial results

---

AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-08-04 (Crawled : 11:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 66.3% | O: -0.53% H: 0.0% C: 0.0%
ACIU | $2.38 8.8K |

Health Technology

| -16.2% | O: 8.8% H: 0.0% C: -3.56%
update financial results

---

Arkuda Therapeutics to Present Update on ARKD-104, its First-in-Class Oral Development Candidate for the Treatment of Frontotemporal Dementia
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 67.9% | O: -0.04% H: 1.43% C: 0.95%
arkd-104 candidate update treatment dementia therapeutics

---

Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 65.67% | O: -0.7% H: 0.12% C: -2.36%
disease update alzheimer's aaic

---

IN8bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-12 (Crawled : 12:00) - globenewswire.com
INAB | $1.04 -0.95% 110K |

| -54.13% | O: 2.75% H: 10.71% C: 4.91%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 72.37% | O: 1.06% H: 1.22% C: -1.3%
update financial results

---

Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-09 (Crawled : 12:00) - precisionbiosciences.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 5.51% | O: -2.35% H: 1.06% C: 0.48%
NVS | $93.815 1.35% 410K |

Health Technology

| -11.28% | O: -0.38% H: 0.39% C: 0.18%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 73.5% | O: -0.22% H: 0.89% C: -0.79%
DTIL | $9.985 -6.86% 93K |

Health Technology

| 1161.18% | O: -2.94% H: 5.45% C: 3.03%
business update financial results

---

Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 75.23% | O: -0.08% H: 0.74% C: -0.07%
MRUS | $40.04 -1.06% 230K |

Health Technology

| 118.23% | O: 4.36% H: 8.41% C: 5.96%
INCY | $52.45 -0.7% 530K |

Health Technology

| -20.2% | O: 0.85% H: 1.46% C: -0.28%
business update financial results

---

AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-04-28 (Crawled : 12:20) - biospace.com/
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 92.33% | O: 1.96% H: 1.59% C: -0.54%
ACIU | $2.38 8.8K |

Health Technology

| 26.6% | O: 0.0% H: 3.46% C: 3.19%
update financial results

---

Veru Announces Preclinical Results from Expanded Sabizabulin Program into Influenza-Induced Severe Acute Respiratory Distress Syndrome and Provides Update on COVID-19 Program
Published: 2023-04-04 (Crawled : 14:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 114.05% | O: 0.38% H: 1.97% C: 0.72%
VERU | $1.365 -3.87% 1.7M |

Health Technology

| 24.56% | O: 7.89% H: 1.63% C: -9.76%
covid-19 sabizabulin respiratory update preclinical program results

---

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M |

Health Technology

| -6.09% | O: -0.58% H: 0.6% C: 0.38%
LLY | $728.765 -2.3% 1.5M |

Health Technology

| 127.87% | O: -0.56% H: 1.24% C: 0.58%
ACIU | $2.38 8.8K |

Health Technology

| 3.48% | O: 0.0% H: 6.09% C: 0.43%
year update financial results

---

Gainers vs Losers

77%

23%

Top 10 Gainers

AGBA | News | $1.22 205.0% 86M |

Finance

EGOX | $0.054 50.0% 290M |

CHRO | $1.66 35.51% 70K |

n/a

INDO | $5.43 33.09% 10M |

Energy Minerals

NVFY | $2.71 28.44% 31M |

Consumer Durables

ZCMD | $1.86 28.28% 29M |

Commercial Services

RWOD | $10.08 26.05% 5.6M |

n/a

HUSA 4 | $2.07 23.95% 2.1M |

Energy Minerals

TPET | $0.4001 22.02% 35M |

n/a

SRFM 4 | $0.6 21.29% 850K |

n/a

---

Your saved searches

---